Flower Orthopedics has announced the full market launch of the Flower E-Kit. According to the company, this product is a first of its kind, and contains all of the necessary cannulated and plating instruments in one multifunctional single-use instrument kit. Combine it with the new IndicationCube, says Flower, and it is an all-in-one solution.
Flower Orthopedics: Full Launch of E-Kit
1 min read Premium comments
Secondary
“The E-Kit represents the next generation of single-use instrument kits. Using the E-Kit a physician is able, with only the four instruments in the kit, to complete complex foot reconstruction or even a comminuted ankle fracture procedure in significantly less time, ” said Flower President and CEO Oliver Burckhardt in the June 7, 2016 news release.
“The IndicationCube, a new exciting addition to the FlowerCube portfolio, is specifically intended for foot ankle and ankle indications where plates are often used in combination with cannulated screws. It houses all of the implants that can be applied using the E-Kit. As both the E-Kit and IndicationCube prove, Flower Orthopedics is all about driving Surgical Efficiency.”
As indicated in the news release, the product is, “Designed to reduce surgical steps, the E-Kit allows the surgeon to quickly and efficiently position all implants of midfoot, forefoot and ankle constructs. Compared to the current market standard, the Flower E-Kit effectively replaces two complete orthopedic instrument trays, reducing the waste associated with costly sterilization cycles in the operative facility.”
Burckhardt told OTW, “The E-Kit is about increasing the efficiency of the Flower Ready-For-Surgery platform. Containing all of the instruments and implants needed in complex foot and ankle procedures, the E-Kit and the IndicationCube replace at least two competitive trays from the OR and from the costly sterilization-decontamination cycle. The E-Kit and IndicationCube are the foundation of several future innovations that allow Flower to continue to reduce the overall cost providing orthopedic care.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.